Sep 05, 2019 / 02:15PM GMT
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Okay. Good. Great. Good morning, everyone. My name is Eric Coldwell. I cover pharma services and health care supply chain with Baird. It's a pleasure to have Charles River with us this morning, always one of the highlights of the conference, one of the most requested companies. So Jim, thanks for being here and giving us your valued time.
For those of you who don't know Jim Foster, obviously, the CEO of the firm, been with Charles River for many years. And side note, personal note, Charles River -- I always like saying this because it makes Jim like me, Charles River is my longest-standing buy rating of all of my existing coverage, which is always fun.
For those who are new in the audience, Charles River, obviously, a company founded on research products, models used in nonclinical and preclinical research and the services that they wrap around it. About almost 20 years ago now, I guess, started to move into the nonclinical safety assessment world, what is often euphemistically
Charles River Laboratories International Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 05, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers